Top Markets
Coin of the day
Kidswell Bio Corporation Kidswell Bio Corporation

Kidswell Bio Corporation

4584
Peringkat dalam Saham #24931
Kidswell Bio Corporation, headquartered in Tokyo, Japan, specializes in the... Kidswell Bio Corporation, headquartered in Tokyo, Japan, specializes in the development of pharmaceutical treatments for rare and complex diseases. The company, which was founded in 2001 and operated as Gene Techno Science Co.,Ltd. until rebranding in July 2021, maintains a robust pipeline of therapeutic candidates. This includes GND-004, designed for both ophthalmic conditions and oncology, and GND-007, aimed at immunological disorders. Their portfolio also features a range of antibodies being developed for cancer therapies. Further expanding its research, the GBS series encompasses GBS-001, GBS-004, and GBS-010 for oncology; GBS-005 for immunological diseases; GBS-007 and GBS-012 for eye-related ailments; GBS-008 for infectious diseases; and GBS-011 for renal conditions. Additionally, Kidswell Bio is progressing GCT-101 for alveolar clefts, GCT-102 for congenital isolated hypoganglionosis, alongside other investigational products addressing ophthalmologic disorders, cerebral palsy, peripheral nerve palsy, fractures, and spinal cord injuries.
Harga Saham
$1.11
Kapitalisasi Pasar
$55.05M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-36.23%
Negara
JP
Perdagangan Kidswell Bio Corporation (4584)

Kategori

Riwayat harga saham Kidswell Bio Corporation (4584)
Harga penutupan tertinggi: $1.05 pada 2026-08-01

Harga penutupan terendah: $4.24 pada 2012-11-01
Riwayat harga saham Kidswell Bio Corporation dari 2012 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 6.26%
2025 85.15%
2024 -18.76%
2023 -55.53%
2022 -51.13%
2021 -14.74%
2020 -45.17%
2019 17.42%
2018 -35.72%
2017 71.03%
2016 51.70%
2015 11.50%
2014 -41.27%
2013 43.55%
2012 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$760.05 8.39%
CH
$130.43 397.46%
US